Those who suffer from debilitating migraines may soon be able receive an outpatient procedure that can help alleviate their pain, as reported by Nature World News.
The U.S. Food and Drug Administration (FDA) recently approved a TMS device for people who suffer from migraines that are preceded by an aura – characterized by a tingling sensation in the extremities and flashes of light or blind spots in a person’s vision. The device uses magnetic energy to stimulate the occipital cortex – an area of the brain involved in visual processing – in order to alleviate migraine pain.
In a trial conducted by the FDA, 201 migraine sufferers tested the device when they experienced head pain. Overall, 38 percent of patients using the device experienced relief from migraine pain within two hours, compared to just 17 percent of people who were given a fake version of the device.
While the TMS has not been proven to completely eliminate all migraine symptoms, it does help relieve migraine pain. The FDA noted that the device doesn’t provide relief for other symptoms of migraines, including sensitivity to light, sensitivity to sound and nausea.